News

  • Announcements

The Power of Absci’s Platform for AI Drug Discovery Demonstrated in New Preprint Manuscript on bioRxiv

08.18.2022

Read More

  • All
  • Announcements
  • Blog Posts
  • Media Highlights
  • Recent Press Releases

Nov 16, 2022

Therapeutic Antibody Design – The AI-assisted Future Of Lead Optimization

  • Blog Posts

Nov 02, 2022

Absci Welcomes Meta Senior Executive to Board of Directors

  • Recent Press Releases

Nov 01, 2022

Why I’m Excited to Join the Protein Drug Creation Revolution at Absci

  • Blog Posts

Oct 04, 2022

Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer

  • Recent Press Releases

Sep 14, 2022

Antibody Drug Conjugates: ‘Intelligent Drugs that Seek and Destroy Cancer’

  • Blog Posts

Sep 11, 2022

Absci Reports Third Quarter 2022 Financial Results

  • Recent Press Releases

Sep 01, 2022

Absci to Participate in the Morgan Stanley Global Healthcare Conference

  • Announcements

Aug 24, 2022

Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company Showcase

  • Announcements

Aug 18, 2022

The Power of Absci’s Platform for AI Drug Discovery Demonstrated in New Preprint Manuscript on bioRxiv

  • Announcements

Find out more

Contact Us